Israel
Medizinprodukt-Marktintelligenz für Israel. Regulatorische Änderungen, Wettbewerber und Beschaffungstrends.
Neueste Signale
A study evaluates the safety and efficacy of the PulseNmore FC device in IVF treatment for 100 women.
The PMD-200 pain monitor study at a neurointensive care unit has been terminated.
Emerging technologies are redefining the medical device landscape, as noted by entrepreneur Eyal Lifschitz.
The EUM device was validated as a reliable non-invasive method for monitoring uterine contractions and fetal heart rate.
A study is recruiting to evaluate the WP device against PSG for detecting sleep disorders.
The study compares the WatchPAT device to PSG for diagnosing obstructive sleep apnea in patients aged 5 to 90.
A study on the REN device shows potential preventive benefits for migraines in adolescents through frequent use.
The Serenno Medical device aims to automate urine output and IAP measurements for improved accuracy in critical care.
The Hanita CleaRing device reduces Nd:YAG treatment rates in cataract patients by inhibiting PCO post-lens extraction.
A study investigates a white light imaging device for 3D ocular tissue imaging, focusing on dry eye syndrome.
A study shows infrared spectroscopy can detect pressure injuries early, completed by Rambam Health Care Campus.
The UroShield device is being evaluated for its efficacy in preventing UTIs in patients with urinary catheters.
The VasQ device aims to improve hemodynamic conditions in AVFs for hemodialysis patients with ESRD.
A completed study developed a device to monitor eyelid motion using glasses with sensors for analysis.
A study will use a wearable device to predict aggression in pediatric psychiatric patients under 12 years old.
A new mechanical device for tattoo removal is being evaluated in a study comparing needle washing fluids.
The Xal-Ease device aims to improve Xalatan/Xalacom instillation efficiency in glaucoma patients, potentially reducing costs.
The study evaluated the Endograb laparoscopic retractor's safety and efficacy, reducing abdominal incisions.
The study evaluates the safety and efficacy of the Occiflex Robotic System for chronic neck pain treatment.
The UroShield System uses Active NanoShield technology to prevent biofilm formation in urinary catheters via ultrasound.